SLNSW-Olaparib combined with chemotherapy for recurrent...-TN_cdi_proquest_miscellaneous_1751214689

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Full title: Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Author/creator: Oza, Amit M, Prof, Cibula, David, Prof, Benzaquen, Ana Oaknin, MD, Poole, Christopher, Prof, Mathijssen, Ron H J, Prof, Sonke, Gabe S, MD, Colombo, Nicoletta, MD, Špaček, Jiří, MD, Vuylsteke, Peter, MD, Hirte, Holger, MD, Mahner, Sven, MD, Plante, Marie, MD, Schmalfeldt, Barbara, Prof, Mackay, Helen, MD, Rowbottom, Jacqui, PhD, Lowe, Elizabeth S, MD, Dougherty, Brian, PhD, Barrett, J Carl, PhD, Friedlander, Michael, Prof.

Call Numbers:

Record Identifier: TN_cdi_proquest_miscellaneous_1751214689

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751214689

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Record identifier

    TN_cdi_proquest_miscellaneous_1751214689

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751214689

    Share

    Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751214689

    Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Full title

    Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Author / Creator

    Oza, Amit M, Prof ; Cibula, David, Prof ; Benzaquen, Ana Oaknin, MD ; Poole, Christopher, Prof ; Mathijssen, Ron H J, Prof ; Sonke, Gabe S, MD ; Colombo, Nicoletta, MD ; Špaček, Jiří, MD ; Vuylsteke, Peter, MD ; Hirte, Holger, MD ; Mahner, Sven, MD ; Plante, Marie, MD ; Schmalfeldt, Barbara, Prof ; Mackay, Helen, MD ; Rowbottom, Jacqui, PhD ; Lowe, Elizabeth S, MD ; Dougherty, Brian, PhD ; Barrett, J Carl, PhD ; Friedlander, Michael, Prof

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2015, Vol.16 (1), p.87-97

    Record Identifier

    TN_cdi_proquest_miscellaneous_1751214689

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Administration, Intravenous Administration, Oral Adult Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use BRCA1 Protein - genetics BRCA2 Protein - genetics Cancer Cancer therapies Carboplatin - administration & dosage Chemotherapy Clinical medicine Deoxyribonucleic acid Disease-Free Survival Diseases DNA Drug Administration Schedule Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - adverse effects Female Gene mutations Hematology, Oncology and Palliative Medicine Hospitals Humans Middle Aged Molecular Targeted Therapy Monosaccharides Mutation Neoplasm Grading Neoplasm Recurrence, Local Neoplasms, Cystic, Mucinous, and Serous - drug therapy Neoplasms, Cystic, Mucinous, and Serous - enzymology Neoplasms, Cystic, Mucinous, and Serous - mortality Neoplasms, Cystic, Mucinous, and Serous - pathology Ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - enzymology Ovarian Neoplasms - genetics Ovarian Neoplasms - mortality Ovarian Neoplasms - pathology Paclitaxel - administration & dosage Patients Phthalazines - administration & dosage Phthalazines - adverse effects Piperazines - administration & dosage Piperazines - adverse effects Poly(ADP-ribose) Polymerase Inhibitors Poly(ADP-ribose) Polymerases - metabolism Relapse SDG 3 - Good Health and Well-being Sugars Time Factors Treatment Outcome Tumors Young Adult

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_miscellaneous_1751214689

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751214689

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections